Julie Clark
Directeur Technique/Scientifique/R&D chez OPTHEA LIMITED
Postes actifs de Julie Clark
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OPTHEA LIMITED | Directeur Technique/Scientifique/R&D | 01/02/2024 | - |
Historique de carrière de Julie Clark
Anciens postes connus de Julie Clark
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Directeur Technique/Scientifique/R&D | - | 22/10/2021 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2011 | 01/10/2012 |
| IVERIC BIO, INC. | Corporate Officer/Principal | - | - |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Directeur Technique/Scientifique/R&D | - | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Formation de Julie Clark
| Wake Forest School of Medicine | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
| Wake Forest University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Australie | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| OPTHEA LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Bourse
- Insiders
- Julie Clark
- Expérience